Berberine inhibits the proliferation of human uterine leiomyoma cells

Fertility and Sterility

Volumn 103, Issue 4, 2015, Pages 1098-1106

  Wu, Hsiao Li ^a   Chuang, Tung Yueh ^a   Al Hendy, Ayman ^a   Diamond, Michael P ^a   Azziz, Ricardo ^a   Chen, Yen Hao ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Anti tumorigenic; Antineoplastic; Berberine; Fibroids; Leiomyomas; Treatment; Uterus

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERINE; CYCLIN A1; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; ESTRADIOL; LIPOCORTIN 5; PROGESTERONE; PROPIVERINE; PROTEIN BAX; PROTEIN P21; PROTEIN P53; RNA; ANTIESTROGEN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MYOMETRIUM; PRIORITY JOURNAL; UPREGULATION; UTERUS MYOMA; ANTAGONISTS AND INHIBITORS; DRUG ANTAGONISM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LEIOMYOMA; PATHOLOGY; TUMOR CELL CULTURE; UTERINE NEOPLASMS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BERBERINE; CELL PROLIFERATION; DRUG ANTAGONISM; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMA; PROGESTERONE; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 84930800111     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.01.010     Document Type: Article

References (45)

1. Stewart EA. Uterine fibroids. Lancet 2001;357:293-8.
2. Sankaran S, Manyonda IT. Medical management of fibroids. Best Pract Res Clin Obstet Gynaecol 2008;22:655-76.
3. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7.
4. Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: A systematic review and meta-analysis. Hum Reprod 2010;25: 418-29.
5. Shen SH, Fennessy F,McDannold N, Jolesz F, Tempany C. Image-guided thermal therapy of uterine fibroids. Semin Ultrasound CT MR 2009;30:91-104.
6. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 2012;206:211.e1-9.
7. Yi ZB, Yan Y, Liang YZ, Bao Z. Evaluation of the antimicrobial mode of berberine by LC/ESI-MS combined with principal component analysis. J Pharm Biomed Anal 2007;44:301-4.
8. Liu JC, Chan P, Chen YJ, Tomlinson B, Hong SH, Cheng JT. The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats. Pharmacology 1999;59:283-9.
9. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004;203:127-37.
10. Zhang W, Xu YC, Guo FJ, Meng Y, Li ML. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin Med J (Engl) 2008; 121:2124-8.
11. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10:1344-51.
12. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol 2009;126:5-17.
13. Choi MS, Yuk DY, Oh JH, Jung HY, Han SB, Moon DC, et al. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis. Anticancer Res 2008;28:3777-84.
14. Wang YX, Kong WJ, Li YH, Tang S, Li Z, Li YB, et al. Synthesis and structureactivity relationship of berberine analogues in LDLR up-regulation and AMPK activation. Bioorg Med Chem 2012;20:6552-8.
15. Patil JB, Kim J, Jayaprakasha GK. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol 2010;645:70-8.
16. Wu K, Yang Q, Mu Y, Zhou L, Liu Y, Zhou Q, et al. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/beta-catenin signaling. Int J Oncol 2012;41:292-8.
17. Qi HW, Xin LY, Xu X, Ji XX, Fan LH. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J Transl Med 2014;12:22.
18. Mittal A, Tabasum S, Singh RP. Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft. Phytomedicine 2014;21:340-7.
19. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 2009;20:757-69.
20. Carney SA, Tahara H, Swartz CD, Risinger JI, He H, Moore AB, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest 2002;82:719-28.
21. Hou YY, Cao WW, Li L, Li SP, Liu T, Wan HY, et al. MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett 2011;307:182-90.
22. StrzalkaW,ZiemienowiczA. Proliferating cellnuclear antigen (PCNA): A key factor in DNA replication and cell cycle regulation. Ann Bot 2011;107:1127-40.
23. Doree M, Hunt T. From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner? J Cell Sci 2002;115:2461-4.
24. Fung TK, Ma HT, Poon RY. Specialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor. Mol Biol Cell 2007;18:1861-73.
25. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A 1995;92:8493-7.
26. Tsai SJ, Lin SJ, Cheng YM, Chen HM, Wing LY. Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas. J Clin Endocrinol Metab 2005;90:3715-23.
27. Hallstrom TC, Mori S, Nevins JR. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 2008;13:11-22.
28. Ke X, Dou F, Cheng Z, Dai H, Zhang W, Qu X, et al. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation. Eur J Obstet Gynecol Reprod Biol 2013;168:199-203.
29. Munoz LE, Maueroder C, Chaurio R, Berens C, Herrmann M, Janko C. Colourful death: six-parameter classification of cell death by flow cytometry- dead cells tell tales. Autoimmunity 2013;46:336-41.
30. Biermann M, Maueroder C, Brauner JM, Chaurio R, Janko C, Herrmann M, et al. Surface code-biophysical signals for apoptotic cell clearance. Phys Biol 2013;10:065007.
31. Li X, Marani M, Yu J, Nan B, Roth JA, Kagawa S, et al. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res 2001;61:186-91.
32. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22: 9030-40.
33. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004;303:1010-4.
34. Nierth-Simpson EN, Martin MM, Chiang TC, Melnik LI, Rhodes LV, Muir SE, et al. Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation. Endocrinology 2009;150:2436-45.
35. Kim JJ, Sefton EC. The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Mol Cell Endocrinol 2012;358:223-31.
36. Pei L, Melmed S. Isolation and characterization of a pituitary tumortransforming gene (PTTG). Mol Endocrinol 1997;11:433-41.
37. Edwards J,Mukherjee R,MunroAF, WellsAC,AlmushatatA, Bartlett JM.HER2 and COX2 expression in human prostate cancer. Eur J Cancer 2004;40:50-5.
38. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009;30:377-86.
39. Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK. Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E(2) and prostaglandin E(2) receptors. Carcinogenesis 2011;32:86-92.
40. Fu L, Chen W, Guo W, Wang J, Tian Y, Shi D, et al. Berberine targets AP-2/ hTERT, NF-kappaB/COX-2, HIF-1alpha/VEGF and cytochrome-c/caspase signaling to suppress human cancer cell growth. PLoS One 2013;8:e69240.
41. Kuo CL, Chi CW, Liu TY. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo 2005;19:247-52.
42. Liu B, Wang G, Yang J, Pan X, Yang Z, Zang L. Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PLoS One 2011;6:e21416.
43. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006;5:296-308.
44. Wang L, Liu L, Shi Y, Cao H, Chaturvedi R, Calcutt MW, et al. Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PLoS One 2012;7:e36418.
45. Chidambara Murthy KN, Jayaprakasha GK, Patil BS. The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur J Pharmacol 2012;688:14-21.